Pipeline

Our Pipeline of multiple FIC targets addressing diverse adipose mechanisms and indications

Indication
Mechanism
Discovery
Target validation
Preclinical candidate
IND-enabling (DC)
Clinical
MW01
Indication:
Obesity
Stage: IND-enabling (DC)
Q1 2027
NHP PD data
MW02
Indication:
Obesity
Stage: Preclinical candidate
MW03
Indication:
Obesity
Stage: Preclinical candidate
MW05
Indication:
Lipid lowering
Stage: Preclinical candidate
MW08
Indication:
Obesity
Stage: Preclinical candidate
MW09
Indication:
Obesity
Mechanism:
Stage: Preclinical candidate
MWₙ
Indication:
Obesity and other indications
Stage: Target validation